CD30 and ALK combination therapy has high therapeutic...

  • Main
  • 2020 / 7
  • CD30 and ALK combination therapy has high therapeutic...
British Journal of Cancer 2020 / 7

CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma

Fordham, Ashleigh M., Xie, Jinhan, Gifford, Andrew J., Wadham, Carol, Morgan, Lisa T., Mould, Emily V. A., Fadia, Mitali, Zhai, Lei, Massudi, Hassina, Ali, Zara S., Marshall, Glenn M., Lukeis, Robyn E
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-020-0996-2
Date:
July, 2020
File:
PDF, 1.61 MB
2020
Conversion to is in progress
Conversion to is failed